Meeting
Abstract Number: 0385
SHM Converge 2025
Background: Patients with substance use disorders (SUDs) are at high risk for blood borne viruses (BBV) and sexually transmitted infections (STIs).1 Syphilis infections, in particular, have dramatically increased over the past decade. More patients with syphilis infections are reporting injection drug use.2 Hospitalization is considered a “reachable moment” for this vulnerable patient population.3 Yet, screening [...]
Abstract Number: 0403
SHM Converge 2025
Background: Sodium-glucose transport protein 2 inhibitors (SGLT-2i) are antidiabetic drugs that have shown to aid in all-cause/cardiovascular mortality along with progression of renal disease. Though SGLT2i have many benefits, there are many instances where these medications need to be held or discontinued; preoperatively (72h-92h prior to surgery), hypotension, reduced oral intake, decrease in eGFR, urinary [...]